140 related articles for article (PubMed ID: 8619010)
1. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.
Pearl SM; Johnson DW; Glick SD
Psychopharmacology (Berl); 1995 Oct; 121(4):470-5. PubMed ID: 8619010
[TBL] [Abstract][Full Text] [Related]
2. Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.
Pearl SM; Maisonneuve IM; Glick SD
Neuropharmacology; 1996; 35(12):1779-84. PubMed ID: 9076757
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.
Pearl SM; Hough LB; Boyd DL; Glick SD
Pharmacol Biochem Behav; 1997 Aug; 57(4):809-15. PubMed ID: 9259010
[TBL] [Abstract][Full Text] [Related]
4. Ibogaine-like effects of noribogaine in rats.
Glick SD; Pearl SM; Cai J; Maisonneuve IM
Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
[TBL] [Abstract][Full Text] [Related]
5. Modulation of morphine-induced antinociception by ibogaine and noribogaine.
Bagal AA; Hough LB; Nalwalk JW; Glick SD
Brain Res; 1996 Nov; 741(1-2):258-62. PubMed ID: 9001731
[TBL] [Abstract][Full Text] [Related]
6. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
Sershen H; Harsing LG; Hashim A; Lajtha A
Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
[TBL] [Abstract][Full Text] [Related]
7. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment.
Szumlinski KK; Maisonneuve IM; Glick SD
Brain Res; 2000 May; 864(1):13-23. PubMed ID: 10793182
[TBL] [Abstract][Full Text] [Related]
8. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
Glick SD; Maisonneuve IM; Pearl SM
Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
[TBL] [Abstract][Full Text] [Related]
9. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
Maisonneuve IM; Rossman KL; Keller RW; Glick SD
Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
Szumlinski KK; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
[TBL] [Abstract][Full Text] [Related]
11. Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference.
Luxton T; Parker LA; Siegel S
Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):857-72. PubMed ID: 8870069
[TBL] [Abstract][Full Text] [Related]
12. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.
Maisonneuve IM; Keller RW; Glick SD
Eur J Pharmacol; 1991 Jun; 199(1):35-42. PubMed ID: 1893925
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Levant B; Pazdernik TL
Brain Res; 2004 Apr; 1003(1-2):159-67. PubMed ID: 15019575
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.
Maisonneuve IM; Glick SD
Eur J Pharmacol; 1999 Oct; 383(1):15-21. PubMed ID: 10556676
[TBL] [Abstract][Full Text] [Related]
15. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.
French ED; Dillon K; Ali SF
Life Sci; 1996; 59(12):PL199-205. PubMed ID: 8809219
[TBL] [Abstract][Full Text] [Related]
16. Effects and aftereffects of ibogaine on morphine self-administration in rats.
Glick SD; Rossman K; Steindorf S; Maisonneuve IM; Carlson JN
Eur J Pharmacol; 1991 Apr; 195(3):341-5. PubMed ID: 1868880
[TBL] [Abstract][Full Text] [Related]
17. Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.
Szumlinski KK; Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 1999 Jul; 63(3):457-64. PubMed ID: 10418788
[TBL] [Abstract][Full Text] [Related]
18. The development and expression of locomotor sensitization to nicotine in the presence of ibogaine.
Zubaran C; Shoaib M; Stolerman IP
Behav Pharmacol; 2000 Aug; 11(5):431-6. PubMed ID: 11103895
[TBL] [Abstract][Full Text] [Related]
19. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
Glick SD; Maisonneuve IM; Szumlinski KK
Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
[TBL] [Abstract][Full Text] [Related]
20. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
